Japan· JP-1190004C1025
チアプリド塩酸塩
A medicinal product containing チアプリド塩酸塩, registered in Japan by 日医工, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- チアプリド塩酸塩
- Manufacturer
- 日医工
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
チアプリド塩酸塩 in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTIAPRAZentiva, k.s., Praha
- PolandTiaprid PMCSMedezin Sp. z o.o.
- GermanyTiaprid -BiomoAet, De
- FranceTIAPRIDAL 100 mg, comprimé sécableNEURAXPHARM FRANCE
- SpainTIAPRIZAL 100 mg COMPRIMIDOSNeuraxpharm Spain S.L.U.
- BelgiumTiapridal 100 mgNeuraxpharm Belgium
- SwitzerlandTiapridal, TablettenNeuraxpharm Switzerland AG
- ItalySEREPRILE*10 fiale IM EV 100 mg 2 mlNEURAXPHARM ITALY SpA
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Delpral, Tiaprid G.L.
- Belgium · Tiapridal
- Bulgaria · Тиаприд G.L.
- Czechia · Tiapra, Tiapralan
- Germany · Tiaprid 1 A Pharma, Tiaprid 1a Pharma
- Spain · Tiaprizal
- France · Tiapridal, Tiapride Sandoz
- Hungary · Tiager, Tiapridal
- Italy · Italprid, Sereprile
- Lithuania · Hipokin, Tiapridal
- Luxembourg · Tiapridal
- Poland · Tiaprid Pmcs, Tiapridal
- Portugal · Tiaprida Generis, Tiapridal
- Romania · Tiapridal
- Slovakia · Tiaprid Fmk, Tiaprid Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb80bd45-2f67-4e77-a466-9fbedea7b5fe GET /v1/drugs/fb80bd45-2f67-4e77-a466-9fbedea7b5fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1190004C1025",
"category": "内用薬",
"price_yen": 15.2,
"generic_name": "チアプリド塩酸塩",
"product_name_jp": null,
"therapeutic_class": "1190",
"transitional_expiry": null
}See everything about チアプリド塩酸塩.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.